N-3 Fatty Acids for Hypertriglyceridemia in Patients Taking Second-Generation Antipsychotics-Reference-Cited by-同舟云学术

N-3 Fatty Acids for Hypertriglyceridemia in Patients Taking Second-Generation Antipsychotics

Published:2013-07 Issue:2 Volume:7 Page:73-77A
ISSN:1935-1232
Container-title:Clinical Schizophrenia & Related Psychoses
language:en
Short-container-title:Clinical Schizophrenia & Related Psychoses

Author:

Fetter Jeffrey Charles,Brunette Mary,Green Alan I.

Publisher

Longdom Group

Subject

Psychiatry and Mental health,General Medicine

Reference54 articles.

1. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight statesPreventing Chronic Disease 2006

2. Excess mortality of mental disorder

3. Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study

4. Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study;Schizophrenia Research;2021-04

2. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association;Circulation;2019-09-17

3. A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone;Schizophrenia Research;2019-02

4. Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder;Bipolar Disorders;2018-02-26

5. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial;Clinical Nutrition;2015-06